Recent News

• 09.10.2025 - EUDA Signs Letter of Intent to Potentially Acquire GO POSB
• 09.04.2025 - EUDA Strategically Expands into T-Cell Immunotherapy – Strengthening Its Stem Cell Therapy Portfolio
• 08.28.2025 - EUDA Signs Letter of Intent to Potentially Acquire Chemokine Pte Ltd
• 08.26.2025 - EUDA Expands Wellness Product Portfolio With A Next-Generation Immune Health Supplement
• 04.24.2025 - EUDA Partners with Authorized Distributor of Guangdong Cell Biotech to Offer Stem Cell Therapies to Customers in Singapore and Malaysia

Recent Filings

• 09.10.2025 - EX-99.1 EX-99.1
• 09.10.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 09.04.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 09.04.2025 - EX-99.1 EX-99.1
• 08.28.2025 - EX-99.1 EX-99.1
• 08.28.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.26.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.26.2025 - EX-99.1 EX-99.1
• 08.08.2025 - 6-K/A Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.08.2025 - 424B5 Prospectus [Rule 424(b)(5)]